Should I Buy ALUR? ALUR 2026 Analysis

Should You Buy Allurion Technologies Inc (ALUR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.100

1 Day change

2.80%

52 Week Range

6.490

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: the chart is still in a confirmed downtrend and there are no Intellectia buy signals to override that.
The latest reported fundamentals show sharp revenue contraction and widening losses, which typically keeps pressure on micro/small-cap medical-tech names.
Sentiment inputs (news momentum grading, neutral hedge/insider activity, no notable options positioning) do not show a clear catalyst-driven reason to chase today’s bounce.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bearish structure (SMA_200 > SMA_20 > SMA_5) indicates the primary trend is down.
Momentum: MACD histogram at -0.0352 (below zero) and only “negatively contracting” suggests downside momentum is easing, but not a confirmed reversal.
RSI: RSI_6 = 40.87 (neutral-to-weak), not an oversold snap-back signal.
Price levels: Current price 1.37 is below the Pivot (1.406) → still under a key inflection level.
Support/Resistance: Near-term support at S1 1.226 (then S2 1.115). Upside resistance at 1.406 (pivot) then R1 1.585.
Pattern-based outlook provided: ~80% chance of +0.78% next day, but -0.93% next week and -7.29% next month → near-term bounce risk, medium-term downside bias remains.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Reported open-interest/volume fields are largely missing, so options positioning is not giving a strong directional read.
Historical volatility is very high (150.89), implying large swings are common; without supportive trend signals, that volatility is not an advantage for a straightforward “buy now.”

Technical Summary

Sell

Buy

Positive Catalysts

- Short-term price strength: regular session +8.87% with additional post-market +1.48% suggests buyers showed up, potentially for a brief rebound.
- MACD downside momentum is contracting, which can precede a stabilization phase if price reclaims the 1.406 pivot.
- No significant negative insider/hedge-fund trading trend flags in the provided data (both neutral).

Neutral/Negative Catalysts

- News sentiment: ALUR flagged with an F momentum grade (weak price performance trend), aligning with the bearish technicals.
- Medium-term statistical trend provided points to downside over the next month (-7.29%).
- No event-driven catalyst in the news summary (no product, regulatory, earnings, or strategic headline cited) to justify buying into strength.
- No congress trading data and no noted influential/political buying to support a sentiment tailwind.

Financial Performance

Latest quarter provided: 2025/Q3.
Revenue: 2,658,000, down -50.48% YoY → sharp contraction.
Net income: -11,884,000, down -236.03% YoY → losses widened significantly.
EPS: -1.53, down -145.00% YoY → profitability trend deteriorating.
Gross margin: 49.06%, down -15.37% YoY → margin compression adds fundamental pressure.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating trend or price target changes were provided in the dataset, so Wall Street’s current pro/con framing cannot be validated here.
Practical takeaway from available data: in absence of supportive analyst upgrades/targets, the trade thesis relies mainly on technicals and fundamentals—both currently skew negative.

1 Analyst Rating

Wall Street analysts forecast ALUR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALUR is 6 USD with a low forecast of 6 USD and a high forecast of 6 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.070

Low

Averages

High

Current: 1.070

Low

Averages

High

Chardan Capital

Keay Nakae

Hold

Maintains

$2.5

AI Analysis

2025-03-27

Reason

Chardan Capital

Keay Nakae

Price Target

$2.5

AI Analysis

2025-03-27

Maintains

Hold

Reason

Chardan notes that Allurion has announced additional data evaluating the use of its Allurion Balloon in combination with patients be treated with GLP1 therapy, which the analyst calls "intriguing," especially the increase in lean body mass. However, the firm believes a more rigorous randomized controlled study will be needed to further validate this finding. Chardan has a Neutral rating and $2.50 price target on Allurion shares.

Roth MKM

Jason Wittes

Strong Buy

Reiterates

$16

2025-03-21

Reason

Roth MKM

Jason Wittes

Price Target

$16

2025-03-21

Reiterates

Strong Buy

Reason

ALUR Should I Buy

ALUR Should I Buy

Should You Buy Allurion Technologies Inc (ALUR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch